Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up

被引:29
|
作者
Spiridigliozzi, Gail A. [1 ]
Keeling, Lori A. [2 ,4 ]
Stefanescu, Mihaela [3 ,4 ]
Li, Cindy [3 ,4 ]
Austin, Stephanie [3 ,4 ]
Kishnani, Priya S. [3 ,4 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA
[2] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA
[3] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Box 103856, Durham, NC 27710 USA
关键词
Infantile-onset Pompe; Cognitive; Academic; Visual-motor integration; ENZYME REPLACEMENT THERAPY; WHITE-MATTER; DISORDERS; CHILDREN;
D O I
10.1016/j.ymgme.2017.04.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examines the long-term cognitive and academic outcomes of 11 individuals with infantile onset Pompe disease (IOPD) (median age = 11 years, 1 month, range = 5 years, 6 months through 17 years of age) treated with enzyme replacement therapy from an early age. All participants (7 males, 4 females) were administered individual intelligence tests (Wechsler or Leiter scales or both), a measure of their academic skill levels (Woodcock-Johnson Tests of Achievement), and a screening measure of visual-motor integration ability (Beery-Buktenica). Consistent with our earlier findings, median IQ scores for the entire group on the Wechsler (median = 84) and Leiter (median = 92) scales continue to fall at the lower end of the average range compared to same-aged peers. The median scores for the group on a measure of visual-motor integration (median = 76), visual perception (median = 74) and motor coordination (median = 60) were below average. Two distinct subgroups emerged based on participants' average or below average performance on the majority of academic sub tests. Those participants with below average academic skills (n = 6) demonstrated average nonverbal cognitive abilities on the Leiter, but had weaknesses in speech and language skills and greater medical involvement. Their profiles were more consistent with a learning disability diagnosis than an intellectual disability. Two of these participants showed a significant decline (15 and 23 points, respectively) on repeated Wechsler scales, but one continued to earn average scores on the Leiter scales where the verbal and motor demands are minimal. Participants with average academic skills (n = 5) demonstrated average cognitive abilities (verbal and nonverbal) on the Wechsler scales and less medical involvement. Their speech and language skills appeared to be more intact. However, both groups earned below average median scores on the Beery-Buktenica motor coordination task. This study highlights the importance of using appropriate tests to capture both verbal and nonverbal abilities, considering each individual's motor skills, speech and language abilities, hearing status and native language. This will allow for a more accurate assessment of whether there is a learning disability or an intellectual disability. Long-term outcomes may be related to the stability of an individual's expressive and/or receptive language abilities over time. Changes in the speech and language domain may account for the decline in IQ observed in some IOPD long-term survivors, reflecting a learning disability rather than a decline in overall cognition or an intellectual disability. These observations, in conjunction with neuroimaging, will further our understanding of the neurocognitive profile of long-term IOPD survivors. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 137
页数:11
相关论文
共 50 条
  • [1] Long-term outcome and unmet needs in infantile-onset Pompe disease
    Hahn, Andreas
    Schaenzer, Anne
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (13)
  • [2] Longitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease
    Zeng, Yin-Ting
    Hwu, Wuh-Liang
    Torng, Pao-Chuan
    Lee, Ni-Chung
    Shieh, Jeng-Yi
    Lu, Lu
    Chien, Yin-Hsiu
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2017, 21 (03) : 485 - 493
  • [3] Long-Term Follow-Up in Infantile-Onset Lambert-Eaton Myasthenic Syndrome
    Portaro, S.
    Parisi, D.
    Polizzi, A.
    Ruggieri, M.
    Andreetta, F.
    Bernasconi, P.
    Toscano, A.
    Rodolico, C.
    JOURNAL OF CHILD NEUROLOGY, 2014, 29 (09) : NP58 - NP61
  • [4] Long-term follow-up in infantile-onset SCAR18: A case report
    Iodice, Alessandro
    Spagnoli, Carlotta
    Cangini, Margherita
    Soliani, Luca
    Rizzi, Susanna
    Salerno, Grazia Gabriella
    Frattini, Daniele
    Pisani, Francesco
    Fusco, Carlo
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 77 : 232 - 234
  • [5] Long-term follow-up of 64 children with classical infantile-onset Pompe disease since 2004: A French real-life observational study
    Tardieu, Marine
    Cudejko, Celine
    Cano, Aline
    Hoebeke, Celia
    Bernoux, Delphine
    Goetz, Violette
    Pichard, Samia
    Brassier, Anais
    Schiff, Manuel
    Feillet, Francois
    Rollier, Paul
    Mention, Karine
    Dobbelaere, Dries
    Fouilhoux, Alain
    Espil-Taris, Caroline
    Eyer, Didier
    Huet, Frederic
    Walther-Louvier, Ulrike
    Barth, Magalie
    Chevret, Laurent
    Kuster, Alice
    Lefranc, Jeremie
    Neveu, Julien
    Pitelet, Gaele
    Ropars, Juliette
    Rivier, Francois
    Roubertie, Agathe
    Touati, Guy
    Vanhulle, Catherine
    Tardieu, Emilie
    Caillaud, Catherine
    Froissart, Roseline
    Champeaux, Murielle
    Labarthe, Francois
    Chabrol, Brigitte
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (09) : 2828 - 2837
  • [6] Enzyme replacement therapy for infantile onset Pompe disease: long term follow-up results.
    Kishnani, P
    Nicolino, M
    Voit, T
    Tsai, CH
    Herman, G
    Waterson, J
    Rogers, RC
    Levine, J
    Amalfitano, A
    Charrow, J
    Tiller, G
    Schaefer, B
    Kolodny, E
    Corzo, D
    Chen, YT
    MOLECULAR GENETICS AND METABOLISM, 2004, 81 (03) : 169 - 169
  • [7] Infantile-onset Alexander disease in a child with long-term follow-up by serial magnetic resonance imaging: A case report
    Nishibayashi F.
    Kawashima M.
    Katada Y.
    Murakami N.
    Nozaki M.
    Journal of Medical Case Reports, 7 (1)
  • [8] THE LONG-TERM FOLLOW-UP OF ENZYME REPLACEMENT TREATMENT IN LATE ONSET POMPE DISEASE
    Molnar, Maria Judit
    Borsos Beata
    Vardi, Visy Kotalin
    Grosz Zoltan
    Sebok Agnes
    Dezsi Livia
    Almassy Zsuzsanna
    Kerenyi Levente
    Jobbagy Zita
    Javor Laszlo
    Bidlo Judit
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2020, 73 (5-6): : 151 - 159
  • [9] Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease
    Kenney-Jung, Daniel
    Korlimarla, Aditi
    Spiridigliozzi, Gail A.
    Wiggins, Walter
    Malinzak, Michael
    Nichting, Gretchen
    Jung, Seung-Hye
    Sun, Angela
    Wang, Raymond Y.
    Al Shamsi, Aisha
    Phornphutkul, Chanika
    Owens, James
    Provenzale, James M.
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [10] Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: Long-term follow-up
    Spiridigliozzi, Gail A.
    Heller, James H.
    Kishnani, Priya S.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2012, 160C (01) : 22 - 29